These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23938874)

  • 1. Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine).
    Tripathy SK; Surada RK; Manne RK; Mobin SM; Santra MK; Patra S
    Dalton Trans; 2013 Oct; 42(39):14081-91. PubMed ID: 23938874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterisation and antibacterial activity of [(p-cym)RuX(L)](+/2+) (X = Cl, H2O; L = bpmo, bpms) complexes.
    Tripathy SK; Taviti AC; Dehury N; Sahoo A; Pal S; Beuria TK; Patra S
    Dalton Trans; 2015 Mar; 44(11):5114-24. PubMed ID: 25675378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
    Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
    Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism.
    Demoro B; de Almeida RF; Marques F; Matos CP; Otero L; Costa Pessoa J; Santos I; Rodríguez A; Moreno V; Lorenzo J; Gambino D; Tomaz AI
    Dalton Trans; 2013 May; 42(19):7131-46. PubMed ID: 23519281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study.
    Bíró L; Farkas E; Buglyó P
    Dalton Trans; 2012 Jan; 41(1):285-91. PubMed ID: 22051630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.
    Sommer MG; Kureljak P; Urankar D; Schweinfurth D; Stojanović N; Bubrin M; Gazvoda M; Osmak M; Sarkar B; Košmrlj J
    Chemistry; 2014 Dec; 20(52):17296-9. PubMed ID: 25376425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands.
    Grau J; Noe V; Ciudad C; Prieto MJ; Font-Bardia M; Calvet T; Moreno V
    J Inorg Biochem; 2012 Apr; 109():72-81. PubMed ID: 22387934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
    David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
    J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
    Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
    Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure, and reactivity of new tetranuclear Ru-Hbpp-based water-oxidation catalysts.
    Francàs L; Sala X; Escudero-Adán E; Benet-Buchholz J; Escriche L; Llobet A
    Inorg Chem; 2011 Apr; 50(7):2771-81. PubMed ID: 21366245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New RuII (arene) complexes with halogen-substituted bis- and tris(pyrazol-1-yl)borate ligands.
    Orbisaglia S; Di Nicola C; Marchetti F; Pettinari C; Pettinari R; Martins LM; Alegria EC; da Silva MF; Rocha BG; Kuznetsov ML; Pombeiro AJ; Skelton BW; Sobolev AN; White AH
    Chemistry; 2014 Mar; 20(13):3689-704. PubMed ID: 24616192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
    Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
    Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipophilicity-dependent ruthenium N-heterocyclic carbene complexes as potential anticancer agents.
    Lv G; Guo L; Qiu L; Yang H; Wang T; Liu H; Lin J
    Dalton Trans; 2015 Apr; 44(16):7324-31. PubMed ID: 25797411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
    Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
    J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-pot synthesis of symmetric and asymmetric p-quinone ligands and unprecedented substituent induced reactivity in their dinuclear ruthenium complexes.
    Schweinfurth D; Das HS; Weisser F; Bubrin D; Sarkar B
    Inorg Chem; 2011 Feb; 50(3):1150-9. PubMed ID: 21214266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time.
    Rafols L; Josa D; Aguilà D; Barrios LA; Roubeau O; Cirera J; Soto-Cerrato V; Pérez-Tomás R; Martínez M; Grabulosa A; Gamez P
    Inorg Chem; 2021 Jun; 60(11):7974-7990. PubMed ID: 33979132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.